Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record.

White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium

Konstantinov, Konstantin B., Cooney, Charles L.·2015·Journal of Pharmaceutical Sciences

Abstract

There is a growing interest in realizing the benefits of continuous processing in biologics manufacturing, which is reflected by the significant number of industrial and academic researchers who are actively involved in the development of continuous bioprocessing systems. These efforts are further encouraged by guidance expressed in recent US FDA conference presentations. The advantages of continuous manufacturing include sustained operation with consistent product quality, reduced equipment size, high-volumetric productivity, streamlined process flow, low-process cycle times, and reduced capital and operating cost. This technology, however, poses challenges, which need to be addressed before routine implementation is considered. This paper, which is based on the available literature and input from a large number of reviewers, is intended to provide a consensus of the opportunities, technical needs, and strategic directions for continuous bioprocessing. The discussion is supported by several examples illustrating various architectures of continuous bioprocessing systems. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Overview

Integrity signals

Registry

Crossref · 10.1002/jps.24268

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. Anderson, 2001, Practical use of continuous processing in developing and scaling up, Org Proc Res Devt, 5, 613, 10.1021/op0100605 · DOI
  2. Thomas, 2008, Batch-to-continuous—Coming out of age, Chem Eng, 805, 38
  3. Laird, 2007, Continuous processes in small-scale manufacture, Org Process Res Dev, 11, 927, 10.1021/op700233e · DOI
  4. Robinson, 1994, “Characterization of a recombinant antibody produced in the course of a high yield fed-batch process, Biotechnol Bioeng, 44, 727, 10.1002/bit.260440609 · DOI
  5. Reid, 2010, Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down Study of the effect of harvesting by centrifugation on the post-translational Modification Profile, Biotechnol Bioeng, 107, 85, 10.1002/bit.22790 · DOI
  6. Pacis, 2011, Effects of cell culture conditions on antibody N-linked glycosylation—What affects high MAnnose 5 glycoform, Biotechnol Bioeng, 108, 2348, 10.1002/bit.23200 · DOI
  7. Clincke, 2013, Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVEBioreactorTM —Part II: Applications for antibody production and cryopreservation, Biotechnol Prog, 29, 768, 10.1002/btpr.1703 · DOI
  8. Vogel, 2002, Continuous annular chromatography: General characterization and application for the isolation of recombinant protein drugs, Biotech Bioeng, 80, 559, 10.1002/bit.10411 · DOI
  9. Napadensky, 2013, Continuous countercurrent tangential chromatography for monoclonal antibody purification, Separation Sci Technol, 48, 1289, 10.1080/01496395.2013.767837 · DOI
  10. Pollock, 2013, Fed-batch and perfusion culture processes: Operational, economic and environmental feasibility under uncertainty, Biotechnol Bioeng, 110, 206, 10.1002/bit.24608 · DOI · Paper page
  11. Hammerschmidt, 2014, Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation, Biotechnology J, 9, 766, 10.1002/biot.201300480 · DOI
  12. Pollock, 2013, Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture, J Chromatogr A, 1284, 17, 10.1016/j.chroma.2013.01.082 · DOI
  13. Warikoo, 2012, Integrated continuous production of recombinant therapeutic proteins, Biotechnol Bioeng, 109, 3018, 10.1002/bit.24584 · DOI · Paper page

Cited by

See all 306

Metadata

Authors
Konstantinov, K. B., & Cooney, C. L.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2015-03
Volume
104
Issue
3
Pages
813-820
ISSN
0022-3549
Cited by
306
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium. https://app.cochat.ai/papers/10.1002/jps.24268
The paper
Konstantinov, K. B., & Cooney, C. L. (2015). White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.24268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.